PTGS2 and neoplasm: Periodic treatment with the Bcl2 family inhibitors can target and decrease Cox2-expressing senescent cells and dramatically reduce tumorigenesis, suggesting that senescent PanIN cells provide essential support to tumor growth, at least in part, by their expression of the proinflammatory Cox2 enzyme [87].